Table 4 Adjusted comparison of endotype survival outcomes.
Model | Variable | Odds Ratio | 95% CI | P-value |
|---|---|---|---|---|
HE as reference | HFA | 0.803 | 0.747–0.862 | < 0.001*** |
RFH | 0.889 | 0.821–0.964 | 0.004** | |
AA | 0.999 | 0.935–1.066 | 0.968 | |
HTN | 0.962 | 0.919–1.007 | 0.095 | |
Age (years) | 0.991 | 0.991–0.992 | < 0.001*** | |
GCS score | 1.028 | 1.024–1.031 | < 0.001*** | |
Male sex | 0.999 | 0.966–1.033 | 0.944 | |
HFA as reference | HE | 1.246 | 1.159–1.339 | < 0.001*** |
RFH | 1.108 | 1.011–1.214 | 0.0284* | |
AA | 1.244 | 1.139–1.359 | < 0.001*** | |
HTN | 1.198 | 1.123–1.279 | < 0.001*** | |
RFH as reference | HFA | 0.903 | 0.824–0.989 | 0.028* |
HE | 1.125 | 1.038–1.219 | 0.004** | |
AA | 1.123 | 1.021–1.235 | 0.017* | |
HTN | 1.082 | 1.004–1.166 | 0.040* | |
AA as reference | HFA | 0.804 | 0.736–0.878 | < 0.001*** |
HE | 1.001 | 0.938–1.069 | 0.968 | |
RFH | 0.890 | 0.810–0.979 | 0.017* | |
HTN | 0.963 | 0.899–1.032 | 0.288 | |
HTN as reference | HFA | 0.834 | 0.782–0.891 | < 0.001*** |
HE | 1.040 | 0.993–1.088 | 0.095 | |
RFH | 0.924 | 0.857–0.996 | 0.040* | |
AA | 1.038 | 0.969–1.112 | 0.288 |